Chemoinformaics analysis of Aristolochic acid II
| Molecular Weight | 311.249 | nRot | 2 |
| Heavy Atom Molecular Weight | 302.177 | nRig | 22 |
| Exact Molecular Weight | 311.043 | nRing | 4 |
| Solubility: LogS | -4.005 | nHRing | 1 |
| Solubility: LogP | 3.72 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 3 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
| nHA | 5 | APOL | 38.6331 |
| nHD | 1 | BPOL | 14.5349 |
| QED | 0.443 |
| Synth | 2.508 |
| Natural Product Likeliness | 0.458 |
| NR-PPAR-gamma | 0.671 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.797 |
| MDCK | 0.0000691 |
| BBB | 0.177 |
| PPB | 0.975125 |
| VDSS | 0.365 |
| FU | 0.0177194 |
| CYP1A2-inh | 0.883 |
| CYP1A2-sub | 0.135 |
| CYP2c19-inh | 0.167 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.622 |
| CYP2c9-sub | 0.267 |
| CYP2d6-inh | 0.755 |
| CYP2d6-sub | 0.134 |
| CYP3a4-inh | 0.304 |
| CYP3a4-sub | 0.032 |
| CL | 2.532 |
| T12 | 0.492 |
| hERG | 0.117 |
| Ames | 0.966 |
| ROA | 0.035 |
| SkinSen | 0.927 |
| Carcinogencity | 0.923 |
| EI | 0.857 |
| Respiratory | 0.934 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.693551 |